BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 2004
View Archived Issues
Specific protein kinase inhibitors with strong anticytomegaloviral activity
Read More
Progen Industries reviews 2004 highlights
Read More
TheraCIM hR3 awarded orphan drug status for glioma
Read More
GenVec licenses PEDF rights for ocular diseases
Read More
Treatment begins in phase II study of Albuferon plus ribavirin for hepatitis C
Read More
Enrollment completed in phase II study of HGS-ETR1 for NSCLC
Read More
RiVax, first ricin vaccine to enter human clinical trials
Read More
Phase II talabostat study in NSCLC advances to second stage
Read More
NPS to include two-year data in Preos NDA filing
Read More
IND filing for phase III study of Aridol for asthma
Read More
Estrogen analogues show neuroprotective, sex-independent effects in ischemic injury model
Read More
Retinoic acid metabolism blocking agents inhibit tumor growth in vivo
Read More
Clinical benefits found for infliximab, pimecrolimus in Behcet's disease / News in Context
Read More
Fenofibrate plus ezetimibe reported more effective than either drug alone in mixed hyperlipidemia
Read More
Myogen completes two pivotal clinical trials on enoximone in CHF
Read More
Cilnidipine for the treatment of arrhythmia
Read More
A new method for the treatment of Parkinson's disease claimed by Newron
Read More
Vertex scientists describe novel protein kinase inhibitors
Read More
Serotonin reuptake inhibitors for treatment of affective disorders claimed in Lundbeck patents
Read More
Antimitotic KSP kinesin inhibitors in early development at Merck
Read More
Tryptanthrin derivatives for treatment of highly proliferative diseases, such as leukemia
Read More